Page 87 - JSOM Fall 2019

References
1. Galante HS, et al. Tranexamic acid use in trauma: effective
but not without consequences. Trauma Treat. 2013;2(4). doi:
10.4172/2167-1222.1000179
2. Roberts I, et al. The CRASH-2 trial: a randomised controlled
trial and economic evaluation of the effects of tranexamic acid on
death, vascular occlusive events and transfusion requirement in
bleeding trauma patients. Clin Govern. 2013;18(3). doi:10.1108/
cgij.2013.24818caa.005
3. Levy JH. Antifibrinolytic therapy: new data and new concepts.
Lancet. 2010;376:3–4.
4. Okamoto S, Hijikata-Okunomiya A, Wanaka K, et al. Enzyme-
controlling medicines: introduction. Semin Thromb Hemost. 1997;
23:493–501.
5. Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-
analysis and meta-regression of the effect of tranexamic acid on
surgical blood loss. Br J Surg. 2013;100(10):1271–1279.
6. WOMAN Trial Collaborators. Effect of early tranexamic acid
administration on mortality, hysterectomy, and other morbid-
ities in women with post-partum haemorrhage (WOMAN): an
international, randomised, double-blind, placebo- controlled trial.
Lancet. 2017;389(10084):2105–2116.
7. CRASH-2 Collaborators, Roberts I, Shakur H, et al. The impor-
tance of early treatment with tranexamic acid in bleeding trauma
patients: an exploratory analysis of the CRASH-2 randomised
controlled trial. Lancet. 2011;377(9771):1096–1101.
8. Gayet-Ageron A, et al. Effect of treatment delay on the effective-
ness and safety of antifibrinolytics in acute severe haemorrhage: a
meta-analysis of individual patient-level data from 40 138 bleed-
ing patients. 2017.
9. Morrison JJ, et al. Military Application of Tranexamic Acid in
Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg.
2012;147(2):113.
10. Anker-Møller T, Troldborg A, Sunde N, et al. Evidence for the use
of tranexamic acid in subarachnoid and subdural hemorrhage: a
systematic review. Semin Thromb Hemost. 2017;43(7):750–758.
11. Nishihara S, Hamada M. Does tranexamic acid alter the risk
of thromboembolism after total hip arthroplasty in the absence
of routine chemical thromboprophylaxis? J Bone Joint Surg Br.
2017;97(4):458–462.
12. Yang Z, Chen W, Wu L. Effectiveness and safety of tranexamic
acid in reducing blood loss in total knee arthroplasty: a me-
ta-analysis. J Bone Joint Surg Am. 2012;94(13):1153–1159.
13. Gausden EB, Garner MR, Warner SJ, et al. Tranexamic acid in hip
fracture patients: A protocol for a randomised, placebo-controlled
trial on the efficacy of tranexamic acid in reducing blood loss in
hip fracture patients. BMJ Open. 2016;6(6).
14. Schauer SG, et al. Prehospital administration of tranexamic acid
by ground forces in Afghanistan. J Spec Oper Med. 2017;17(3):
55–58.
15. Tactical Combat Casualty Care Guidelines. http://www.usaisr
.amedd.army.mil/pdfs/TCCC_Guidelines_140602.pdf. Accessed 21
February 2017.

Tranexamic Acid in the Prehospital Setting | 85